December 8, 2023 • The Plaza • New York, NY
Black Tie Optional

 
Featuring The Pulse-Setter Awards
 
Master of Ceremonies Matt Iseman Emmy Award-Winning TV Host and Comedian

The Annual Pulse of the City Gala®

Heart disease remains the number-one cause of death globally and affects millions around the world. The Cardiovascular Research Foundation® (CRF®) is one of the world's leading nonprofit organizations dedicated to interventional cardiology innovation, research, and education. For more than 30 years, we have been helping doctors improve survival and quality of life for people with heart and vascular disease. Our signature scientific symposium is Transcatheter Cardiovascular Therapeutics® (TCT®), the world's premier meeting in interventional cardiovascular medicine.

Our annual fundraiser has become a hallmark event of the holiday season, drawing hundreds of luminaries in cardiovascular medicine and other medical disciplines, as well as high-ranking leaders in government, business, and the community who are passionate about improving treatment for patients with heart and vascular disease. Funds raised at The Pulse of the City Gala® allow CRF® to pursue innovative areas of research, train tomorrow's physician leaders, and educate the medical community and public about heart health.

In 2022, CRF® inaugurated the Pulse-Setter Awards to shine a spotlight on unique individuals and programs who are using innovation to make a positive impact on health care. The evening honored those whose passion and commitment to patients address unmet needs and improve access to health care.

With your help, we can significantly reduce the worldwide health and economic burden of heart disease.

 

Presenting The 2023 Honorees

Pulse-Setter
Leader
Jessica Mega, MD, MPH

Jessica Mega, MD, MPH

For an exceptional leader who demonstrates unwavering commitment to perform at an elevated standard of excellence.

Read More >

Jessica Mega, MD, MPH

Dr. Jessica L. Mega is co-founder of Verily, one of the most impactful and future-determining technology companies that is applying artificial intelligence and data science to accelerate evidence-generation and enable more precise interventions to improve patient outcomes. Verily is part of the Alphabet family of companies, which includes Google.

Read Full Bio >

Pulse-Setter
Champion
L. Nelson Hopkins, MD

L. Nelson Hopkins, MD

For an exceptional individual whose commitment to multidisciplinary collaboration and mentorship in medicine has set new standards for patient care and innovation.

Read More >

L. Nelson Hopkins, MD

A pioneer in the catheter-based treatment of neurovascular diseases including stroke, Dr. L. Nelson (Nick) Hopkins introduced the subspecialty of endovascular neurosurgery in the United States. He also spearheaded one of the world’s largest and most respected stroke centers where innovative methods were developed to treat patients with acute ischemic stroke.

Read Full Bio >

Pulse-Setter
Crusader
Michael R. Jaff, DO

Michael R. Jaff, DO

For demonstrating leadership, effecting positive change, adopting innovative methods to improve access to care, or making an exceptional impact on health care delivery and patient quality of life.

Read More >

Michael R. Jaff, DO

Collaboration and innovation. Those are the bywords for Michael Jaff's career. He is driven by the incredible shift in thought and the massive potential for impact in the evolution of treatment for peripheral vascular diseases from surgical-based to minimally invasive treatment.

Read Full Bio >

Pulse-Setter
Trailblazer
Colby Holtshouse On behalf of the JADA® System/Organon

Colby Holtshouse

On behalf of the JADA® System/Organon

Awarded to a program that creates innovative uses for emerging technologies.

Organon

Read More >

Colby Holtshouse

On behalf of the JADA® System/Organon

Even in the 21st century, a significant number of women die in childbirth. One of the major causes is postpartum hemorrhage — heavy, hard-to-control bleeding that can occur without warning. The World Health Organization (WHO) estimates that 14 million cases of PPH occur globally each year, which in some cases may result in major complications.

Read Full Bio >

Support the Gala

Thank you for your interest in supporting our signature fundraiser. Proceeds benefit the medical research and educational programs of CRF®. Your contribution will make a significant difference in the care of people with heart disease by allowing us to pursue innovative areas of research, train tomorrow's physician leaders, and educate the medical community and the public about heart health. We are deeply grateful for your support.

Reserve a table or purchase tickets using the online form below.

You can make a secure, tax-deductible donation today to CRF® – whether you are able to attend the gala or not.

 

Sponsorships

CRF® offers several underwriting opportunities for the gala. To learn how you can become a sponsor, contact Irma Damhuis at 646-434-4690 or idamhuis@crf.org.

Premier ($55,000) Includes an exclusive VIP cocktail reception, premier seating for 10, special recognition during program, recognition on digital signage, digital advertisement, and logo on the CRF® Gala website

Leadership ($35,000) Includes one table for 10 with premium seating, special thanks announcement during program, recognition on digital signage, digital advertisement, and logo on the CRF® Gala website.

Benefactor ($30,000) Includes seating for 10 and recognition on digital signage.

 

Tickets

Patron ($2,500)Includes preferred seating for one person and recognition on digital signage.

Individual ($1,500)Includes seating for one person.

Fellows Please contact us for more information on special pricing.

 

Ads

Digital Advertisement ($3,500)Please contact Judy Romero at 646-434-4608 or jromero@crf.org.

Past Honorees

About CRF®

LET'S DEFY HEART DISEASE TOGETHER.

For over 30 years, CRF® has been dedicated to helping doctors improve the survival and quality of life for people suffering from heart and vascular disease.

No other organization combines cutting-edge preclinical and clinical research with exceptional medical education to achieve one practical goal: to get better therapies into doctors' hands quickly. By covering all aspects of the research continuum, we're able to accelerate the speed that breakthrough therapies reach patients through doctors, so patients everywhere can live longer, healthier lives.

We need your help to accelerate our efforts so that more people can benefit from the medical advances being made each day. Together, we can give millions of people around the world hope for a brighter, healthier future.

OUR MODEL TO DEFY HEART DISEASE

 

Cardiovascular Research Foundation®

PRESIDENT AND CHIEF EXECUTIVE OFFICER

Juan F. Granada, MD

FACULTY

Alexandre Abizaid, MD, PhD
Andrea Abizaid, MD, PhD
Ziad A. Ali, MD, DPhil
Daniel Burkhoff, MD, PhD
David J. Cohen, MD, MSc
Michael B. Collins, MD
George D. Dangas, MD, PhD
Anthony N. DeMaria, MD
Jose M. Dizon, MD
Philippe Généreux, MD
Isaac George, MD
Juan F. Granada, MD
Rebecca T. Hahn, MD
Allen Jeremias, MD, MSc
Nisha Jhalani, MD
Greg L. Kaluza MD, PhD
Dimitrios Karmpaliotis, MD, PhD
Omar K. Khalique, MD
Ajay J. Kirtane, MD, SM
Susheel Kodali, MD
Ioanna Kosmidou, MD, PhD
Nicholas J. Lembo, MD
Martin B. Leon, MD
Akiko Maehara, MD
Roxana Mehran, MD
Gary S. Mintz, MD
Jeffrey W. Moses, MD
Tamim M. Nazif, MD
Manish A. Parikh, MD
Sahil A. Parikh, MD
LeRoy E. Rabbani, MD
Robert J. Sommer, MD
Torsten P. Vahl, MD
Giora Weisz, MD
Geng-Hua Yi, MD

Board of Directors

Eric B. Woldenberg, Esq - Chairman

Joseph G. Beck
Colette Y. Gardner
Juan F. Granada, MD
William A. Himmelsbach, MPH, FACHE
Steven Hochberg
Karen G. Krasney, JD
Teresa Leste
Frank Litvack, MD
Jeffrey W. Moses, MD
Eric A. Rose, MD
Marvin L. Woodall